​

NKGen Biotech Ownership | Who Owns NKGen Biotech?

OverviewChart

NKGen Biotech Ownership Summary

NKGen Biotech is owned by 3.06% institutional investors, and 96.94% retail investors.

NKGN Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockNKGen Biotech3.06%-96.94%
SectorHealthcare Stocks 279.17%10.51%-189.68%
IndustryBiotech Stocks 63.95%10.67%25.38%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20253-87.50%892,354-88.64%30.42%1-92.31%1-75.00%
Dec 31, 20242426.32%7,853,400109.22%2616.24%1318.18%433.33%
Sep 30, 20241911.76%3,753,6549.86%126.45%1110.00%350.00%
Jun 30, 20241730.77%3,416,87313.18%147.46%1025.00%2100.00%
Mar 31, 20241344.44%3,018,878-19.50%132.33%8-11.11%1-

Insider Transactions Trends

DateBuySell
2025 Q22-
2024 Q4--
2024 Q3--
2024 Q1--

NKGN Ownership FAQ

Who Owns NKGen Biotech?

NKGen Biotech shareholders are primarily institutional investors at 3.06%, followed by 0% insiders and 0% retail investors. The average institutional ownership in NKGen Biotech's industry, Biotech Stocks , is 63.95%, which NKGen Biotech falls below.

Does Blackrock own NKGen Biotech?

BlackRock is not among the top 10 institutional shareholders of NKGen Biotech.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools